Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1980-09-17
1983-06-21
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260112R, 260112B, 422 61, 436 64, G01N 3356, G01N 3358, G01N 3360
Patent
active
043893929
ABSTRACT:
A method for determining the level of tumor associated glycolinkage containing substance (TAG) in a sample of body fluid which comprises reacting the TAG in a sample of the body fluid with a lectin to form a TAG-lectin complex and measuring the amount of the TAG-lectin complex or an unreacted lectin and a kit for use in such method are disclosed. The method is useful for the diagnosis of various cancers or tumors.
REFERENCES:
patent: 4132767 (1979-01-01), Tohmatsu et al.
patent: 4146603 (1979-03-01), Davidson et al.
patent: 4152410 (1979-05-01), Ishii
patent: 4174385 (1979-11-01), Reid
patent: 4196186 (1980-04-01), Bogoch
patent: 4289747 (1981-09-01), Chu
patent: 4298590 (1981-11-01), Bogoch
patent: 4311686 (1982-01-01), Angers et al.
Lotan et al., J. Biolog. Chem., vol. 250, Nov. 1975, pp. 8518-8523.
Prieels et al., Proc. Natl. Acad. Sci. USA, vol. 75, No. 5, May, 1978, pp. 2215-2219.
Pereira et al., Carbohydrate Res., vol. 51, 1976, pp. 107-118.
Nucker Christine M.
Otsuka Pharmaceutical Co. Ltd.
LandOfFree
Determination of tumor associated glycolinkage and diagnosis of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Determination of tumor associated glycolinkage and diagnosis of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Determination of tumor associated glycolinkage and diagnosis of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2110589